Ahlan Bikom Ya fellow investors. We began coverag

Ahlan Bikom Ya fellow investors. We began coverage on GALT back in May of 2018 and been very accurate in out theses. Here's a couple of our first articles.

[https://msmoneymoves.com/august-2/]

[https://msmoneymoves.com/2018/10/02/galectin-blocker-is-front-runner-in-fight-against-nash-cirrhosis/]

[https://msmoneymoves.com/2018/09/20/market-not-grasping-the-magnitude-of-galt-phase1b-keytruda-combo-study/]

and if you like what you read you can subscribe to our free newsletter at

[https://msmoneymoves.com/contact/]

Shukran jami3
Sultan
MS Money Moves
sfbeard@ucdavis.edu
559-381-5250